HU
Heidelberg University Hospital at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Heidelberg University Hospital brings 5 presentations to ESGCT 2026 in Hamburg. Its work centres on AAV vectors derived from human heart tissue and on making them reach heart muscle more selectively. Other strands cover promoters that switch on only in diseased tissue and a regional delivery protocol tested in a large animal model.
| Organization | ESGCT 2026 Attendance |
|---|---|
HU Heidelberg University Hospital Heidelberg, Germany | |
Poster Wed Oct 28 1:30pm–3:30pm Engineering of adeno-associated viral vectors derived from the human heart towards optimal cardiotropism and cardioselectivity in normal and remodelled myocardium Poster Wed Oct 28 1:30pm–3:30pm Unlocking the Power Within: Improving AAV Performance through VP1u Modification Poster Thu Oct 29 2:00pm–4:00pm Characterization of a disease-inducible promoter for cardiac-specific gene therapy Poster Thu Oct 29 2:00pm–4:00pm Development of clinically applicable loco-regional gene transfer protocol in a large animal model Poster Thu Oct 29 2:00pm–4:00pm Evaluation of Transduction Efficiencies of Human-Heart derived AAV Vectors in in vitro cardiomyocyte models |
Instantly find 20 buyers from Heidelberg University Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction